Noile-Immune Biotech Inc. (4893.T)
JPY 163.0
(-1.81%)
JPY 163.0
(-1.81%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.13 Billion JPY | -192.28% |
| 2022 | -386.62 Million JPY | 51.37% |
| 2021 | -795.03 Million JPY | -24.88% |
| 2020 | -636.64 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -340.17 Million JPY | -21.67% |
| 2024 Q2 | -343.24 Million JPY | -0.9% |
| 2023 Q4 | -279.58 Million JPY | -1556.38% |
| 2023 Q3 | -16.87 Million JPY | 95.02% |
| 2023 FY | -1.13 Billion JPY | -192.28% |
| 2023 Q1 | -494.39 Million JPY | -18.28% |
| 2023 Q2 | -339.15 Million JPY | 31.4% |
| 2022 Q4 | -418 Million JPY | 0.0% |
| 2022 FY | -386.62 Million JPY | 51.37% |
| 2021 FY | -795.03 Million JPY | -24.88% |
| 2020 FY | -636.64 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 394.274% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | -114.459% |
| GNI Group Ltd. | 8.09 Billion JPY | 113.961% |
| Linical Co., Ltd. | 338.26 Million JPY | 434.061% |
| Trans Genic Inc. | 4.08 Million JPY | 27762.521% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | 21.415% |
| Soiken Holdings Inc. | -662.2 Million JPY | -70.645% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | 917.932% |
| AnGes, Inc. | -7.43 Billion JPY | 84.807% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 12.275% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 84.29% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 705.276% |
| NanoCarrier Co., Ltd. | -780 Million JPY | -44.873% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | 1.985% |
| CanBas Co., Ltd. | -1.2 Billion JPY | 6.533% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | -39.094% |
| RaQualia Pharma Inc. | -323.66 Million JPY | -249.134% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | 7.377% |
| Kidswell Bio Corporation | -1.42 Billion JPY | 20.538% |
| PeptiDream Inc. | 3.03 Billion JPY | 137.223% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 41.707% |
| Ribomic Inc. | -1.02 Billion JPY | -10.327% |
| SanBio Company Limited | -2.64 Billion JPY | 57.261% |
| Healios K.K. | -3.82 Billion JPY | 70.442% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 3.259% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | 24.14% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | 20.944% |
| StemRIM | -2.02 Billion JPY | 44.114% |
| CellSource Co., Ltd. | 923.14 Million JPY | 222.41% |
| FunPep Company Limited | -933.41 Million JPY | -21.062% |
| Kringle Pharma, Inc. | -854.15 Million JPY | -32.297% |
| Stella Pharma Corporation | -763.74 Million JPY | -47.956% |
| TMS Co., Ltd. | -960.04 Million JPY | -17.705% |
| Cuorips Inc. | -632.18 Million JPY | -78.748% |
| K Pharma,Inc. | 260.33 Million JPY | 534.07% |
| Takara Bio Inc. | 1.48 Billion JPY | 176.352% |
| ReproCELL Incorporated | -31.41 Million JPY | -3497.052% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | 4383.926% |
| StemCell Institute Inc. | 310.98 Million JPY | 463.371% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 889.287% |
| CellSeed Inc. | -846.53 Million JPY | -33.487% |